IRIS
TOSCO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 542
EU - Europa 319
AS - Asia 171
AF - Africa 22
Totale 1.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 523
IT - Italia 171
SG - Singapore 108
NL - Olanda 61
CN - Cina 50
DE - Germania 28
CI - Costa d'Avorio 22
CA - Canada 18
FI - Finlandia 18
IE - Irlanda 16
VN - Vietnam 12
FR - Francia 7
GB - Regno Unito 4
SE - Svezia 4
UA - Ucraina 4
ES - Italia 2
RU - Federazione Russa 2
AL - Albania 1
BE - Belgio 1
IN - India 1
MX - Messico 1
Totale 1.054
Salva come PNG Salva come JPEG
Città #
Chandler 111
Singapore 93
Amsterdam 60
Naples 59
Santa Clara 53
Ashburn 42
Napoli 39
Millbury 18
Ottawa 17
Nanjing 13
Princeton 13
Beijing 12
Dong Ket 12
Lawrence 11
Boston 10
Des Moines 9
Munich 9
Jacksonville 7
Helsinki 6
Mugnano Di Napoli 6
Rome 6
Villaricca 5
Bologna 4
Jiaxing 4
Fairfield 3
Hebei 3
Selargius 3
Shenyang 3
The Dalles 3
Avellino 2
Barcelona 2
Berlin 2
Boardman 2
Changsha 2
Foggia 2
Los Angeles 2
Marcianise 2
Moscow 2
Norwalk 2
Stockholm 2
Tianjin 2
Wilmington 2
Zhengzhou 2
Ann Arbor 1
Birmingham 1
Brussels 1
Casoria 1
Cerro Maggiore 1
Chiusano di San Domenico 1
Civezzano 1
Dallas 1
Falkenstein 1
Fiumicino 1
Formia 1
Frankfurt am Main 1
Hangzhou 1
Hanover 1
Houston 1
Kronberg 1
Kunming 1
Lagundo 1
Lamezia Terme 1
Laojunmiao 1
Lappeenranta 1
Lauria 1
Leawood 1
Mexico City 1
Mountain View 1
Mugnano di Napoli 1
Nanchang 1
Ningbo 1
Orange 1
Padova 1
Palermo 1
Parabiago 1
Potenza 1
Pune 1
Redwood City 1
Santa Maria a Vico 1
Tappahannock 1
Tirana 1
Torre Del Greco 1
Verona 1
Totale 702
Salva come PNG Salva come JPEG
Nome #
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR 83
Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects 61
A complicated association between two different genetic rare disorders: Cystic Fibrosis and Spinal Muscular Atrophy 58
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 56
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 56
Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. 51
Serum and intestinal IGA anti-tissue transglutaminase antibodies in celiac children under 2 years of age. 50
Discriminant score for celiac disease based on immunohistochemical analysis of duodenal biopsies 49
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study 49
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1. 48
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. 47
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 46
Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease. 45
Potential celiac patients: a model of celiac disease pathogenesis. 43
Intestinal deposits of IgA anti tissue transglutaminase antibodies in celiac children under two years of age. 42
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 36
Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in celiac disease. 35
Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine. 35
Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis. 34
Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis 31
NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity 29
A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. 27
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 26
Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function. 24
Elevated sweat chloride test: is it always cystic fibrosis 23
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 9
Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences 7
A Longitudinal Study of Glucose Tolerance in Cystic Fibrosis: The Central Role of Beta Cell Functional Mass 7
Totale 1.107
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 1 1 1 0 7 16 10
2020/202157 9 2 6 6 2 3 4 2 5 4 1 13
2021/2022158 0 0 5 0 1 23 11 1 18 10 41 48
2022/2023309 24 9 9 13 47 32 0 36 75 50 11 3
2023/2024206 5 25 55 17 7 23 4 24 0 6 26 14
2024/2025211 46 63 2 9 48 43 0 0 0 0 0 0
Totale 1.107